Bristol-Myers Squibb CompanyBMYNYSE
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank14
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P14
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -1.74% |
| 2024 | 6.25% |
| 2023 | -2.17% |
| 2022 | -1.28% |
| 2021 | -0.25% |
| 2020 | 60.65% |
| 2019 | 15.94% |
| 2018 | 3.26% |
| 2017 | 12.80% |
| 2016 | 9.12% |